Common interacting residues among the top ten ligands within 4.0 Å against the R1 region of ASFVAP.
| F0329 | F1187 | F1342 | F1384 | F1385 | F1540 | F1792 | F0059 | F1740 | F1771 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ARG 9 | X | X | X | X | X | X | X | |||
| ASL 60 | X | X | X | X | X | X | X | X | X | |
| ASN 55 | X | X | X | X | X | X | X | X | X | |
| ASP 13 | X | X | X | X | X | X | ||||
| CYS 16 | X | X | X | X | X | X | X | X | ||
| CYS 20 | X | X | X | X | X | X | X | X | X | X |
| GLN 57 | X | X | X | X | X | X | X | X | X | |
| GLY 15 | X | X | X | X | X | X | X | X | ||
| GLY 48 | X | X | X | |||||||
| HIS 8 | X | X | X | X | X | X | X | X | X | X |
| ILE 21 | X | X | X | X | X | X | X | X | X | |
| ILE 46 | X | X | X | |||||||
| ILE 56 | X | X | X | X | X | X | X | X | X | |
| PHE 45 | X | X | X | |||||||
| PRO 49 | X | X | X | |||||||
| SER 7 | X | X | X | |||||||
| SER 12 | X | X | X | X | X | X | ||||
| SER 14 | X | X | X | X | X | X | X | X | ||
| THR 17 | X | X | X | X | X | X | X | X | X | X |
| THR 18 | X | X | X | X | X | X | X | X | X | |
| THR 19 | X | X | X | X | X | X | ||||
| VAL 44 | X | X |